- Home
- BLBD vs ZLAB Comparison
BLBD vs ZLAB Comparison
Compare BLBD & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BLBD | ZLAB |
|---|---|---|
| Founded | 1927 | 2013 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Construction/Ag Equipment/Trucks | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.8B |
| IPO Year | 2013 | 2017 |
Fundamental Metrics
Financial Performance| Metric | BLBD | ZLAB |
|---|---|---|
| Price | $57.79 | $18.38 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 7 |
| Target Price | ★ $67.20 | $49.44 |
| AVG Volume (30 Days) | 495.0K | ★ 600.1K |
| Earning Date | 05-11-2026 | 05-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 22.78 | ★ 38.46 |
| EPS | ★ 0.94 | N/A |
| Revenue | ★ $1,480,099,000.00 | $460,156,000.00 |
| Revenue This Year | $4.25 | $22.42 |
| Revenue Next Year | $4.21 | $29.87 |
| P/E Ratio | $61.82 | ★ N/A |
| Revenue Growth | 9.87 | ★ 15.33 |
| 52 Week Low | $30.15 | $15.96 |
| 52 Week High | $62.90 | $44.34 |
Technical Indicators
Market Signals| Indicator | BLBD | ZLAB |
|---|---|---|
| Relative Strength Index (RSI) | 53.02 | 45.16 |
| Support Level | $53.58 | $16.65 |
| Resistance Level | $58.57 | $19.70 |
| Average True Range (ATR) | 2.53 | 0.71 |
| MACD | -0.32 | -0.05 |
| Stochastic Oscillator | 28.48 | 32.34 |
Price Performance
Historical ComparisonAbout BLBD Blue Bird Corporation
Blue Bird Corp is an American bus manufacturing company. It is an independent designer and manufacturer of school buses. The company operates in two segments; the Bus segment which involves the design, engineering, manufacture, and sales of school buses and extended warranties; and the Parts segment which includes the sales of replacement bus parts. Geographically, the company generates a majority of its revenue from its customers in the United States and the rest from Canada and Rest of the world.
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.